Can newborn bovine serum be used instead of fetal bovine serum for adherent tumor cell culture?

Your usage of 500 ml at a time is actually not large, so the absolute price difference between imported fetal bovine serum and newborn calf serum is limited; it only becomes obvious over the long term. Newborn calf serum in stock from regular domestic distributors can usually be shipped in 3-7 days, while imported fetal bovine serum sometimes takes 1-4 weeks. It is recommended that you first ask the distributor to send a 50 ml trial sample or a small package from the same lot, and lock the lot after testing. Be sure to ask clearly about the stock quantity of that lot to avoid the bulk lot changing after a satisfactory trial. Do not only look at "nearly half the price"; you should also confirm whether it is heat-inactivated, irradiated, the filtration level, and whether there is a mycoplasma report.

The core difference between fetal bovine serum and newborn calf serum lies not in any single growth factor, but in overall "cleanliness." Newborn calf serum comes from postnatal calves that have been exposed to colostrum and the external environment, so antibodies, complement, and hemoglobin are typically higher than in fetal bovine serum; some batches are noticeably darker in color, and endotoxin levels may also be elevated. However, for adherent tumor cells such as HeLa and HepG2, which are generally more tolerant than primary cells, direct full replacement carries risk but is worth testing on a small scale. Do not focus only on price—first ask the distributor to provide test reports for hemoglobin, endotoxin, total protein, and hormones, and exclude batches with markedly elevated hemoglobin. You can start with a 50% mixed transition for 1–2 passages, then evaluate adherence, morphology, and doubling time.

I suggest not switching everything all at once. Run three parallel groups: keep the original FBS, 100% newborn calf serum, and FBS:newborn calf serum = 1:1, with replicate wells for each, passage continuously for 3 generations, and record the 24 h attachment rate, morphology, doubling time, and viability. HeLa attachment is relatively stable. If a newborn calf serum lot shows bright edges, sheet-like detachment, or a doubling time prolonged by more than 20%, direct substitution is not recommended. If it is only for maintenance culture or expansion, the risk is relatively low; if drug sensitivity or mechanism experiments are to be performed later, serum variables may introduce batch-to-batch differences, so replacement should be done cautiously.